Chestovent Plus Inhaler

We are authentic trader, supplier and exporter of Chestovent Plus Inhaler in Bengaluru, Karnataka, India available with following details:

Chestovent-Plus Inhaler

Comparison of Ipratropium + Salbutamol Combination with Salbutamol monotherapy
Provides longer duration of action & more reassuring safety profile than lpratropium monotherapy.
Shows additive action to produces greater bronchodilation
Free from cardiovascular complications which are generally present in high doses of beta -2 against drugs.
Indian J allergy asthma immunol 2002. 16(1). 15-21.

Salbutamol Ipratropium+ L-Salbutamol
Onset of actionLess rapidMore rapid than salbutamol
Duration of action Shorter than ipratropium+L-Salbutomol:Longe than salbutamol
Forced vital capacity(FVC)1.942.10%
FEV12%3%
FEV1/ FVC%1.72.1
Forced expiratory volume (FEV)3.864.87
Forced expiratory flow (FEF) 25-75%3.503.86
FIVC2.723.62

Indications:
COPD
Asthma
Chronic bronchitis

Recommended Dosage:
Twice daily